These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 18539649)

  • 1. The role of systemic handling in the pathophysiologic actions of botulinum toxin.
    Al-Saleem FH; Ancharski DM; Ravichandran E; Joshi SG; Singh AK; Gong Y; Simpson LL
    J Pharmacol Exp Ther; 2008 Sep; 326(3):856-63. PubMed ID: 18539649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An initial assessment of the systemic pharmacokinetics of botulinum toxin.
    Ravichandran E; Gong Y; Al Saleem FH; Ancharski DM; Joshi SG; Simpson LL
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1343-51. PubMed ID: 16782822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visualization of binding and transcytosis of botulinum toxin by human intestinal epithelial cells.
    Ahsan CR; Hajnóczky G; Maksymowych AB; Simpson LL
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1028-35. PubMed ID: 16144978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The life history of a botulinum toxin molecule.
    Simpson L
    Toxicon; 2013 Jun; 68():40-59. PubMed ID: 23518040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the major steps in botulinum toxin action.
    Simpson LL
    Annu Rev Pharmacol Toxicol; 2004; 44():167-93. PubMed ID: 14744243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural features of the botulinum neurotoxin molecule that govern binding and transcytosis across polarized human intestinal epithelial cells.
    Maksymowych AB; Simpson LL
    J Pharmacol Exp Ther; 2004 Aug; 310(2):633-41. PubMed ID: 15140915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the mechanisms that underlie absorption of botulinum toxin by the inhalation route.
    Al-Saleem FH; Ancharski DM; Joshi SG; Elias M; Singh A; Nasser Z; Simpson LL
    Infect Immun; 2012 Dec; 80(12):4133-42. PubMed ID: 22966044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that botulinum toxin receptors on epithelial cells and neuronal cells are not identical: implications for development of a non-neurotropic vaccine.
    Elias M; Al-Saleem F; Ancharski DM; Singh A; Nasser Z; Olson RM; Simpson LL
    J Pharmacol Exp Ther; 2011 Mar; 336(3):605-12. PubMed ID: 21106906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhalational poisoning by botulinum toxin and inhalation vaccination with its heavy-chain component.
    Park JB; Simpson LL
    Infect Immun; 2003 Mar; 71(3):1147-54. PubMed ID: 12595426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do the unintended actions of botulinum toxin at distant sites have clinical implications?
    Currà A; Berardelli A
    Neurology; 2009 Mar; 72(12):1095-9. PubMed ID: 19307544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HA proteins of botulinum toxin disrupt intestinal epithelial intercellular junctions to increase toxin absorption.
    Matsumura T; Jin Y; Kabumoto Y; Takegahara Y; Oguma K; Lencer WI; Fujinaga Y
    Cell Microbiol; 2008 Feb; 10(2):355-64. PubMed ID: 17868282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrograde transport and transcytosis of botulinum toxin serotypes to the brain: analysis of potential neurotoxicity.
    Alexiades-Armenakas M
    J Drugs Dermatol; 2008 Oct; 7(10):1006-7. PubMed ID: 19112770
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolism and cytotoxic effects of T-2 toxin and its metabolites on human cells in primary culture.
    Königs M; Mulac D; Schwerdt G; Gekle M; Humpf HU
    Toxicology; 2009 Apr; 258(2-3):106-15. PubMed ID: 19428930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of the sites and characterization of the mechanisms by which anti-light chain antibodies neutralize the actions of the botulinum holotoxin.
    Takahashi T; Joshi SG; Al-Saleem F; Ancharski D; Singh A; Nasser Z; Simpson LL
    Vaccine; 2009 Apr; 27(19):2616-24. PubMed ID: 19428868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulism and vaccines for its prevention.
    Smith LA
    Vaccine; 2009 Nov; 27 Suppl 4():D33-9. PubMed ID: 19837283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tonsils--place of botulinum toxin production: results of routine laboratory diagnosis in farm animals.
    Böhnel H; Wagner C; Gessler F
    Vet Microbiol; 2008 Aug; 130(3-4):403-9. PubMed ID: 18387756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urodynamic and immunohistochemical evaluation of intravesical botulinum toxin A delivery using liposomes.
    Chuang YC; Tyagi P; Huang CC; Yoshimura N; Wu M; Kaufman J; Chancellor MB
    J Urol; 2009 Aug; 182(2):786-92. PubMed ID: 19539320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The structure and mechanism of action of clostridial neurotoxins].
    Parasion S; Bartoszcze M; Gryko R
    Przegl Epidemiol; 2007; 61(3):519-27. PubMed ID: 18069389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrotoxicity caused by brown spider venom phospholipase-D (dermonecrotic toxin) depends on catalytic activity.
    Kusma J; Chaim OM; Wille AC; Ferrer VP; Sade YB; Donatti L; Gremski W; Mangili OC; Veiga SS
    Biochimie; 2008; 90(11-12):1722-36. PubMed ID: 18760322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential entry of botulinum neurotoxin A into neuronal and intestinal cells.
    Couesnon A; Shimizu T; Popoff MR
    Cell Microbiol; 2009 Feb; 11(2):289-308. PubMed ID: 19016790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.